Picture of Agios Pharmaceuticals logo

AGIO — Agios Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Agios Pharmaceuticals Inc reports results for the quarter ended in January 1 - Earnings Summary

* Agios Pharmaceuticals Inc  AGIO.OQ  reported a quarterly
adjusted loss of $2.42​​ per share for the quarter ended January
1, lower than the same quarter last year, when the company
reported EPS of $-1.64.  The mean expectation of ten analysts
for the quarter was for earnings of $1.11 per share. Wall Street
expected results to range from $-1.85 to $12.42 per share.
    * Revenue rose 21.2% to $8.96 million from a year ago;
analysts
expected $9.46 million. 
    * Agios Pharmaceuticals Inc's reported EPS for the quarter
was
$16.22​.
    * The company reported quarterly net income of $947.92
million.
    * Agios Pharmaceuticals Inc shares had risen by 4.2% this
quarter and gained 107.9% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 209.9%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Agios
Pharmaceuticals Inc is $56.00 
This summary was machine generated from LSEG data November 1 at
03:32 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      1.11           -2.42          Missed
 Jun. 30 2024      -1.60          -1.69          Missed
 Mar. 31 2024      -1.65          -1.45          Beat
 Dec. 31 2023      -1.65          -1.72          Missed

Recent news on Agios Pharmaceuticals

See all news